polygammaglutam
acid
extracellular
biopolym
produc
bacillu
sp
noncanon
tolllik
receptor
agonist
show
antivir
efficaci
norovirus
molecular
mass
limit
murin
noroviru
mnv
replic
macrophag
cell
line
induc
interferon
ifn
confer
resist
viral
infectioninduc
cell
death
addit
interf
viral
entri
cell
potent
antivir
state
mount
attribut
upregul
sensor
known
recogn
noroviru
rna
sens
requir
two
accessori
factor
ex
vivo
cultur
mous
ileum
select
increas
express
villi
contrast
induct
neglig
ileal
peyer
patch
pp
express
primarili
induc
replic
mnv
oral
administr
increas
serum
level
without
induc
proinflammatori
cytokin
reduc
mnv
load
ileum
pp
mesenter
lymph
node
mice
result
disclos
nonconvent
signal
ileum
highlight
potenti
use
prophylact
antivir
agent
norovirus
tolllik
receptor
tlr
patternrecognit
receptor
prr
recogn
lipopolysaccharid
lp
gramneg
bacteria
pathogenassoci
molecular
pattern
pamp
signal
activ
myeloid
differenti
primaryrespons
protein
trif
tir
domaincontain
adaptor
proteininduc
depend
pathway
induc
product
proinflammatori
cytokin
interferon
ifn
respect
sinc
discoveri
receptor
lp
sever
nonlp
ligand
mostli
deriv
microb
identifi
role
innat
immun
respons
propos
onset
intestin
inflamm
respons
pamp
colon
possibl
nonlp
ligand
diet
signal
like
play
import
role
intestin
epitheli
cell
iec
immun
cell
includ
macrophag
dendrit
cell
ifn
andor
inflammatori
cytokin
produc
intestin
upon
stimul
pamp
would
system
act
virusinfect
cell
local
andor
far
away
site
ifn
signal
initi
induc
howev
signal
small
intestin
well
character
norovirus
positivesens
singlestrand
rna
virus
belong
calicivirida
famili
human
noroviru
hunov
transmit
via
fecalor
rout
propag
gastrointestin
gi
tract
common
caus
nonbacteri
acut
outbreak
gastroenter
worldwid
across
age
group
noroviru
becom
global
health
burden
due
highsustain
viabil
environ
high
risk
infect
fewer
particl
possibl
caus
chronic
infect
immun
defici
host
well
elderli
infant
emerg
novel
noroviru
strain
despit
breadth
potenti
antivir
drug
test
vitro
use
hunov
replicon
cultur
system
limit
studi
valid
efficaci
drug
vivo
report
safe
prophylact
antivir
drug
could
prevent
onset
publish
xx
xx
xxxx
open
wwwnaturecomscientificreport
scientif
report
acut
gastroenter
immunocompromis
host
absenc
approv
vaccin
specif
antivir
therapi
hunov
develop
prophylact
therapeut
measur
hunov
becom
need
hour
acid
anion
polypeptid
synthes
secret
bacillu
speci
dandor
lglutam
polymer
via
linkag
form
acid
function
group
previous
report
activ
signal
pathway
lead
product
type
interferon
ifn
vitro
display
antivir
activ
sever
acut
respiratori
syndrom
coronaviru
hepat
c
viru
norovirusinfect
cell
product
initi
sens
viral
rna
genom
via
cytoplasm
prr
melanoma
differentiationassoci
gene
follow
phosphoryl
ifn
regulatori
factor
two
independ
pathway
type
ifn
signal
play
major
role
clear
mous
noroviru
hunov
major
ingredi
natto
japanes
tradit
ferment
food
chungkookjang
korean
ferment
season
made
soybean
use
dietari
consumpt
present
studi
investig
whether
nonlp
ligand
could
activ
signal
administ
oral
result
demonstr
induct
peror
administr
without
product
proinflammatori
cytokin
therebi
establish
antivir
state
mous
noroviru
provid
evid
vivo
efficaci
limit
noroviru
infect
highlight
potenti
prophylact
antivir
agent
hunov
infect
caus
epitheli
apoptosi
downregul
level
tight
junction
protein
involv
seal
lead
diarrhea
compar
murin
noroviru
mnv
infect
also
induc
apoptosi
cell
absenc
robust
cell
cultur
system
hunov
use
murin
noroviru
surrog
model
hunov
test
inhibit
virusinduc
cell
death
first
determin
rang
multipl
infect
moi
mnv
viral
infectioninduc
apoptosi
trigger
cours
viral
infect
shown
fig
infect
cell
mnv
moi
produc
viral
rna
copiesml
media
within
h
moi
reduct
viral
rna
level
delay
progress
cell
death
within
day
accordingli
use
moi
infect
cell
assess
impact
shown
fig
treatment
significantli
inhibit
mnv
infectioninduc
cell
death
visual
live
cell
stain
increas
mrna
express
nontreat
control
cell
dosedepend
prevent
virusinduc
cell
death
result
increas
cell
viabil
approxim
nm
fig
demonstr
potent
antivir
activ
noncanon
ligand
mnv
furthermor
treatment
nm
result
decreas
plaqu
titer
significantli
reduc
level
viral
structur
protein
fig
antivir
potenc
compar
supplementari
fig
mean
effect
concentr
nm
inhibitor
recent
shown
effect
control
mnv
infect
antivir
activ
attenu
cotreat
nm
nm
suggest
import
molecular
mass
specif
structur
form
activ
signal
inhibit
noroviru
replic
entri
without
upregul
tlr
express
inhibit
mnv
verifi
measur
intracellular
viral
genom
titer
reduc
viral
genom
titer
cell
infect
low
moi
inhibitori
effect
decreas
slightli
inhibit
moi
fig
addit
led
reduct
level
norwalk
viru
subgenom
replicon
deriv
gi
strain
hunov
nm
cell
line
littl
impact
replic
subgenom
replicon
fig
replicon
cell
line
deriv
human
hepatocellular
carcinoma
cell
line
normal
fail
respond
ligand
lowlevel
express
express
togeth
lack
express
accessori
protein
thu
insuffici
transient
express
associ
accessori
protein
might
contribut
rel
lower
inhibitori
effect
critic
role
accessori
protein
sens
express
investig
human
embryon
kidney
cell
express
endogen
confoc
microscopi
found
sens
intracellular
entri
occur
upon
ectop
express
two
known
accessori
factor
supplementari
fig
substanti
induct
express
activ
observ
express
supplementari
fig
induct
capabl
also
verifi
cell
rnaimedi
deplet
abrog
express
activ
supplementari
fig
pretreat
cell
h
infect
significantli
increas
antivir
activ
compar
postinfect
treatment
h
infect
fig
find
suggest
treatment
predispos
cell
acquir
resist
viral
infect
effect
suppress
mnv
propag
addit
observ
rais
possibl
interf
entri
mnv
accordingli
viru
entri
assay
use
qdotconjug
noroviru
conduct
result
indic
capabl
block
entri
noroviru
cell
fig
e
explain
rel
lower
antivir
activ
replicon
cell
mnvinfect
macrophag
cell
upon
viru
infect
upregul
crosstalk
tlr
signal
pathway
might
alter
sensit
alter
express
profil
tlr
includ
follow
noroviru
infect
investig
mrna
express
level
alter
cell
fig
neither
noroviru
infect
treatment
enhanc
express
immunoblot
analys
detect
indic
stimuli
activ
signal
evidenc
activ
fig
similarli
neither
sensor
noroviru
dsrna
could
potenti
innat
immun
sensor
notyetidentifi
norovirusderiv
induc
pamp
upregul
noroviru
infect
result
suggest
antivir
activ
depend
upregul
tlr
sens
trigger
induct
small
intestin
mous
noroviru
consum
contamin
food
andor
water
penetr
intestin
microfold
cell
infect
target
cell
includ
macrophag
dendrit
cell
mnv
b
cell
hunov
infect
noroviru
propag
sentinel
cell
highli
enrich
peyer
patch
pp
ileum
spread
lymph
node
thu
sought
address
question
whether
trigger
signalingmedi
ifn
product
ileum
compos
epitheli
cell
plu
divers
immun
cell
laminar
propria
pp
exert
antivir
activ
noroviru
end
distal
part
ileum
without
pp
retriev
balbc
mice
treat
cultur
dish
h
ex
vivo
treatment
villi
releas
cultur
media
remain
basal
bodi
ileum
ileal
submucosa
lamina
propria
collect
separ
mrna
level
quantifi
ileal
compart
reversetranscript
quantit
pcr
rtqpcr
fig
interestingli
found
induct
product
villi
compart
ii
iv
pp
basal
bodi
ileum
compart
iii
fig
induct
substanti
villi
deriv
ileum
pp
compart
ii
ileum
without
pp
compart
iv
cell
abund
compart
ii
compart
iv
fig
result
suggest
activ
signal
transvers
epitheli
cell
layer
villi
reach
laminar
propria
bear
macrophag
dendrit
cell
despit
abund
cell
pp
treatment
significantli
induc
mrna
express
suggest
nonrespons
pp
asyetunknown
mechan
parallel
experi
rout
entri
mnv
ileum
monitor
fluoresc
microscop
analysi
qdotconjug
virus
detect
mnv
particl
compart
ii
promin
sign
virion
entri
detect
villi
ileum
without
pp
fig
result
demonstr
mnv
primarili
enter
ileum
bear
pp
intestin
villi
possibl
via
cell
transepitheli
dendrit
cell
confirm
entri
mnv
part
ileum
viral
genom
monitor
upon
deliv
fig
agreement
result
show
mnv
particl
within
villi
consequ
enhanc
mrna
level
detect
ileal
compart
greater
induct
observ
ileal
pp
ipp
earli
viru
infect
supplementari
fig
c
suggest
mnv
enter
villi
reach
pp
infect
ileal
sentinel
cell
result
consist
previou
find
indic
entri
noroviru
cell
within
follicleassoci
epithelium
overli
pp
villi
infect
macrophag
dendrit
cell
activ
investig
mice
ascertain
prophylact
antivir
efficaci
oral
deliv
initi
experi
reveal
product
level
detect
limit
elisa
h
postadministr
mgkg
bodi
weight
per
day
balbc
mice
supplementari
fig
b
result
suggest
weak
ifninduc
activ
ineffici
qdot
qd
conjug
preincub
nm
min
appli
cell
two
hour
adsorpt
viral
entri
quantifi
fluoresc
microscopi
fluoresc
intens
signal
quantifi
imag
analysi
use
imagej
softwar
e
bf
bright
field
imag
scale
bar
shown
inset
transmiss
electron
micrograph
purifi
mnv
particl
neg
stain
uranyl
acet
scale
bar
nm
f
express
cell
infect
moi
shown
gapdhnorm
tlr
express
level
rel
mocktreat
cell
analyz
rtqpcr
h
postinfect
result
two
independ
experi
analyz
triplic
assay
g
immunoblot
assay
repres
activ
nm
infect
moi
without
affect
express
level
phosphoryl
panel
data
mean
sd
statist
signific
differ
group
determin
via
twotail
unpair
student
ttest
p
p
ns
signific
scientif
report
deliveri
intact
conform
ileum
fig
c
mgkg
bodi
weight
administ
mice
day
five
day
serum
level
increas
start
day
fig
induct
neglig
fig
supplementari
fig
product
induc
supplementari
fig
suggest
import
structur
entiti
activ
signal
furthermor
level
mean
valu
neither
decreas
increas
day
day
indic
multipl
administr
induc
toler
blunt
respons
repetit
challeng
among
cytokin
analyz
signific
chang
detect
level
fig
howev
signific
decreas
seen
level
day
respect
level
remain
downregul
day
indic
invers
correl
express
result
consist
recent
studi
suggest
neg
regulatori
role
matur
type
ii
interferon
produc
primarili
activ
cell
detect
vivo
antivir
efficaci
mous
noroviru
test
antivir
activ
vivo
pfu
per
mous
oral
inocul
balbc
mice
receiv
mg
kg
bodi
weight
prior
infect
daili
five
day
induc
express
two
day
mnv
inocul
viral
load
ileum
pp
mesenter
lymph
node
mln
quantifi
use
rtqpcr
plaqueform
assay
administr
result
reduct
genom
titer
ileum
pp
mln
respect
fig
plaqueform
assay
reveal
reduct
mnv
titer
ileum
pp
mln
respect
fig
result
indic
peror
given
possibl
crosstalk
tlr
express
tlr
ileum
alter
respons
noroviru
infect
respons
would
also
affect
ileum
pp
norovirusinfect
mice
show
signific
increas
express
express
level
slightli
increas
though
increas
less
statist
signific
fig
express
figur
inhibit
mice
balbc
mice
week
old
n
per
group
administ
describ
fig
day
twelv
hour
last
administr
mice
inocul
pfu
salin
peror
given
daili
anoth
two
day
viral
genom
infecti
viru
titer
ileum
pp
mln
determin
rtqpcr
plaqueform
assay
b
respect
panel
data
mean
sd
p
twotail
unpair
student
ttest
figur
impact
noroviru
infect
tlr
express
mice
ileum
pp
mln
b
balbc
mice
week
old
n
per
group
infect
fig
retriev
day
viral
infect
express
tlr
mrna
quantifi
describ
fig
data
repres
mean
sd
p
p
p
ns
signific
twotail
unpair
student
ttest
scientif
report
recogn
peptidoglycan
lipoprotein
recogn
bacteri
flagellin
upregul
respect
suggest
possibl
crosstalk
tlr
signal
upregul
tlr
might
contribut
amplif
signal
vivo
sever
tlr
downstream
signal
pathway
share
transcript
factor
use
type
ifn
product
mln
express
level
slightli
decreas
less
fig
result
suggest
differenti
alter
tlr
express
profil
noroviru
infect
ileum
pp
mln
vivo
interestingli
express
profil
tlr
differ
seen
virusinfect
cell
fig
suggest
involv
commens
microbiota
regul
tlr
express
ileum
context
noroviru
infect
mice
thu
ileum
pp
villi
respond
induc
express
level
remain
unchang
although
express
tlr
differenti
affect
noroviru
infect
remain
determin
whether
antivir
activ
noroviru
potenti
amplif
signal
sensit
upregul
tlr
ileum
upon
noroviru
infect
type
ifn
primari
cytokin
induc
rapidli
respons
viral
infect
amplifi
immun
respons
ifnsign
cascad
howev
antivir
effect
intestin
tract
less
clear
present
studi
investig
abil
oral
administ
induc
innat
immun
respons
mount
antivir
state
ileum
result
indic
induct
product
without
elev
level
proinflammatori
cytokin
nonlp
ligand
therebi
predispos
ileum
develop
robust
antivir
innat
immun
noroviru
result
demonstr
induct
type
ifn
product
primarili
activ
trifdepend
pathway
mice
follow
multipl
peror
administr
previou
studi
report
primari
activ
pathway
lp
elicit
secret
numer
proinflammatori
cytokin
ligand
distinct
lp
select
increas
serum
titer
inflammatori
cytokin
name
differ
cytokin
profil
induc
lp
suggest
regulatori
network
differ
lp
control
activ
remain
unclear
whether
nonlp
ligand
includ
endogen
agonist
heat
shock
protein
cholesteryl
ester
hydroperoxid
upon
sens
receptor
also
behav
differ
lp
term
cytokin
profil
anoth
unexpect
find
elev
serum
level
mice
multipl
oral
administr
daili
three
day
neither
increas
decreas
follow
two
addit
oral
administr
result
suggest
absenc
toler
phenomena
normal
seen
endotoxin
lp
wherein
innat
immun
cell
preexpos
lp
becom
refractori
subsequ
challeng
base
result
present
studi
seem
new
class
agonist
select
activ
trifdepend
pathway
iec
normal
nonrespons
ligand
lp
lowlevel
express
receptor
prevent
undesir
inflamm
respons
gut
microbiom
pathogen
gi
tract
minim
express
seen
normal
iec
lamina
propria
rich
scatter
inflammatori
cell
human
biopsi
although
thoroughli
character
previou
studi
indic
express
well
tlr
enterocyt
small
intestin
immunohistochemistri
observ
promin
pattern
apic
basolater
surfac
iec
cell
instead
local
lamina
propria
villi
pp
ileum
thu
result
togeth
previou
find
provid
evid
express
ileum
howev
fine
local
yet
well
defin
low
detect
level
express
explain
role
distal
ileum
continu
expos
microb
product
transfer
colon
render
ileum
iec
hyposensit
pamp
includ
lp
tlr
agonist
therebi
prevent
aberr
product
proinflammatori
cytokin
regard
induct
ex
vivo
cultur
mous
ileum
mice
receiv
peror
surpris
particularli
absenc
upregul
express
cell
mous
ileum
pp
trifdepend
pathway
signal
activ
endosom
upon
intern
complex
accordingli
present
studi
deliv
oral
seem
intern
iec
transvers
tight
junction
enterocyt
intern
sentinel
cell
lamina
propria
induc
product
thu
investig
reach
site
function
interact
occur
ileum
first
barrier
entri
mucu
layer
access
small
intestin
like
occur
cover
thinner
mucu
layer
compar
colon
induct
ifn
product
need
sens
andor
villi
immunostain
reveal
lack
overlap
stain
villin
cytoskelet
protein
specif
villi
ileum
indic
bare
detect
level
apic
site
iec
therefor
hypothes
model
transvers
tight
junction
enterocyt
sens
sentinel
cell
dendrit
cell
within
villi
directli
uptaken
transepitheli
dendrit
supplementari
fig
express
mrna
significantli
enhanc
sole
villi
lack
notic
induct
pp
absenc
respons
pp
result
lack
inflamm
consist
previou
find
suggest
anergi
intestin
macrophag
anergi
mediat
inabl
activ
lowlevel
express
accessori
factor
previous
show
activ
signal
lead
induct
ifn
depend
accessari
factor
present
studi
result
qdotconjug
confirm
necess
sens
depend
pathwaymedi
induct
margin
lpsstimul
macrophag
howev
result
indic
absolut
requir
promin
role
sens
find
suggest
scientif
report
substanti
stimulatori
effect
lamina
propria
rais
interest
possibl
differenti
express
macrophag
dendrit
cell
lamina
propria
pp
current
requir
accessori
factor
sens
variou
nonlp
ligand
remain
larg
unknown
irrespect
mechan
involv
entri
sens
cell
ileum
result
ex
vivo
cultur
indic
stimul
ileum
serum
cytokin
profil
mice
receiv
peror
provid
clue
activ
trifdepend
signal
pathway
ileum
investig
impact
noroviru
infect
induct
result
suggest
lack
signific
alter
express
norovirusinfect
mice
thu
respons
unlik
elev
upon
noroviru
infect
howev
noroviru
infect
led
increas
express
tlr
except
fig
level
increas
upregul
tlr
express
could
part
due
infiltr
leukocyt
infect
ileum
envis
signal
activ
might
potenti
crosstalk
upregul
tlr
among
upregul
tlr
endosom
tlr
includ
may
influenc
sensit
earli
noroviru
infect
current
involv
except
innat
immun
respons
noroviru
infect
remain
unknown
although
noroviru
infect
affect
express
ileum
tlr
respons
colonresid
microbiota
andor
pamp
deriv
might
influenc
downstream
cascad
signal
thu
induct
like
modul
commens
microbiom
larg
intestin
adjac
ileum
type
ifn
play
major
role
clear
mous
noroviru
effect
limit
noroviru
replic
human
noroviru
subgenom
replicon
cultur
system
spite
wellestablish
antivir
potenc
type
ifn
norovirus
ifn
therapi
translat
clinic
practic
subcutan
intramuscular
inject
associ
variou
side
effect
result
demonstr
prophylact
antivir
activ
mice
use
model
enter
virus
infect
small
intestin
accentu
potenti
use
safe
prophylact
candid
treatment
acut
noroviru
infect
although
noroviru
infect
typic
limit
acut
infect
last
day
healthi
subject
associ
signific
clinic
outcom
death
relat
gastroenter
children
year
age
young
children
elderli
immunocompromis
patient
ifn
might
best
treatment
option
use
altern
prophylact
antivir
agent
hunov
import
note
unlik
mnv
replic
mainli
macrophag
dendrit
cell
hunov
shown
replic
b
cell
also
target
iec
therefor
ifn
produc
sentinel
cell
lamina
propria
villi
upon
send
might
restrict
hunov
infect
effect
earli
stage
infect
act
nearbi
iec
paracrin
signal
summari
result
demonstr
oral
administr
induc
product
ileum
without
upregul
express
without
elicit
product
inflammatori
cytokin
specif
induct
featur
highlight
potenti
applic
prophylact
antivir
agent
norovirus
possibl
enter
virus
cell
cultur
murin
macrophag
cell
line
human
embryon
kidney
cell
line
purchas
american
type
cultur
collect
atcc
rockvil
md
usa
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
uml
penicillin
streptomycin
cell
line
stabli
harbor
hunov
norwalk
viru
replicon
cultur
dmem
supplement
fb
mm
lglutamin
uml
penicillin
streptomycin
mm
nonessenti
amino
acid
presenc
mgml
neomycin
sulfat
cell
maintain
co
humidifi
incub
endotoxinfre
differ
averag
molecular
mass
prepar
describ
previous
provid
biolead
daejeon
korea
plasmid
express
human
describ
follow
wash
infect
cell
cultiv
fresh
complet
media
day
viral
stock
prepar
centrifug
harvest
media
g
min
intracellular
viru
particl
recov
three
freezethaw
cycl
harvest
centrifug
g
min
viru
sampl
concentr
use
amicon
ultra
centrifug
filter
unit
molecular
weight
cutoff
kda
merck
millipor
billerica
usa
store
use
crude
mnv
prepar
purif
mnv
perform
previous
describ
modif
briefli
crude
mnv
pellet
ultracentrifug
g
h
pellet
gentli
suspend
suspens
buffer
mm
trishcl
ph
mm
nacl
pellet
ultracentrifug
result
pellet
dissolv
suspens
buffer
subject
sucros
densiti
gradient
centrifug
g
min
collect
mnvcontain
fraction
identifi
sdspolyacrylamid
gel
electrophoresi
page
follow
immunoblot
capsid
protein
fraction
subject
ultracentrifug
describ
obtain
purifi
viru
particl
purifi
viru
particl
suspend
pb
use
viru
entri
experi
plaqueform
assay
plaqueform
assay
perform
describ
previous
briefli
cell
seed
plate
cellswel
cultur
overnight
infect
noroviru
serumfre
dmem
h
infect
cell
wash
remov
inoculum
overlaid
seaplaqu
agaros
wv
lonza
rockland
usa
complet
dmem
high
glucos
follow
day
cultur
plaqu
visual
stain
monolay
cell
neutral
red
cell
viabil
cell
seed
plate
cellswel
grown
overnight
treat
variou
concentr
h
cell
viabil
assess
mt
bromid
assay
describ
previous
rna
extract
rtqpcr
total
rna
extract
mous
ileum
three
piec
segment
ileum
peyer
patch
length
retriev
distal
ileum
distal
part
ileum
open
clean
wash
pb
remov
fecal
matter
homogen
pb
similarli
total
rna
recov
mln
total
rna
cell
cultur
media
extract
trizol
trizol
ls
reagent
invitrogen
carlsbad
ca
usa
respect
norwalk
viru
rna
copi
number
determin
rtqpcr
describ
previous
quantif
mrna
carri
rtqpcr
use
sybr
premix
extaq
takara
japan
specif
primer
set
use
list
supplementari
tabl
specif
primer
human
glyceraldehyd
dehydrogenas
gapdh
describ
previous
express
level
target
gene
normal
express
level
gapdh
mrna
quantifi
use
method
immunoblot
analys
cell
lyse
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
nonidet
supplement
edtafre
proteas
inhibitor
cocktail
roch
diagnost
incub
ice
min
aliquot
clear
cell
lysat
sampl
resolv
sdspage
transfer
onto
nitrocellulos
membran
process
parallel
immunoblot
analys
multipl
protein
membran
immunoblot
specif
antibodi
bound
antibodi
detect
enhanc
chemiluminesc
kit
ge
healthcar
life
scienc
piscataway
nj
usa
analys
cellular
entri
mnv
microscop
analysi
purifi
mnv
conjug
biotin
expos
amin
group
use
sulfonhslcbiotin
ezlink
pierc
rockford
il
usa
accord
manufactur
protocol
biotinyl
detect
use
qdot
streptavidin
conjug
invitrogen
immunohistochemistri
confoc
microscopi
intestin
tissu
mice
embed
frozen
section
compound
surgipath
leica
microsystem
wetzlar
germani
thin
section
fix
paraformaldehyd
block
bsa
pb
incub
h
room
temperatur
mous
monoclon
antibodi
antivillin
rabbit
polyclon
antibodi
gentl
rock
wash
time
pb
appropri
fluorescentconjug
secondari
antibodi
use
visual
antigen
nuclei
visual
stain
dapi
pb
min
confoc
imag
acquir
zeiss
lsm
confoc
laser
scan
microscop
carl
zeiss
oberkochen
germani
zstack
analysi
imag
obtain
along
zaxi
interv
subject
threedimension
analysi
use
zen
softwar
blue
edit
carl
zeiss
enzymelink
immunosorb
assay
elisa
serum
level
measur
use
verikin
mous
elisa
kit
pbl
interferon
sourc
piscataway
nj
usa
detect
limit
mous
elisa
pgml
respect
serum
level
cytokin
quantifi
use
luminex
multiplex
detect
assay
use
antibodyco
magnet
bead
r
system
minneapoli
mn
usa
ex
vivo
cultur
small
intestin
tissu
mous
ex
vivo
cultur
small
intestin
tissu
mous
ileum
isol
cultur
describ
previous
slight
modif
briefli
distal
ileum
segment
cm
length
without
peyer
patch
collect
gentli
open
steril
oper
scissor
wash
five
time
pb
supplement
penicillinstreptomycin
transfer
plate
incub
complet
dmem
vivo
antivir
activ
balbc
mice
week
old
n
per
group
oral
administ
salin
day
day
dose
mgkg
bodi
weight
four
hour
last
administr
total
blood
collect
abdomin
vein
mice
cytokin
analys
use
elisa
test
antivir
efficaci
balbc
mice
week
old
n
per
group
oral
administ
mgkg
bodi
weight
salin
day
day
follow
peror
inocul
mnv
salin
h
last
administr
day
given
daili
anoth
two
day
two
day
inocul
distal
ileum
mln
retriev
mice
analys
intracellular
viral
rna
infecti
viru
titer
homogen
tissu
subject
centrifug
g
min
recov
supernat
pass
pores
membran
filter
filtrat
use
quantif
viru
titer
use
plaqueform
assay
statist
analysi
statist
analysi
perform
use
graphpad
prism
graphpad
prism
softwar
inc
la
jolla
ca
usa
result
present
mean
standard
deviat
sd
least
three
independ
experi
unless
otherwis
state
specif
test
use
determin
statist
differ
note
figur
legend
differ
group
consid
statist
signific
p
author
declar
relev
data
avail
author
upon
request
